INSIDE℠ Chronic Pain Management is a continuing medical education (CME) program designed to guide healthcare providers to more safely and effectively prescribe extended-release/long-acting (ER/LA) opioid analgesics in the management of chronic pain. This program is intended to be fully compliant with the ER/LA Opioids REMS education requirements issued by the FDA.

INSIDE Chronic Pain Management consists of two components:

  1. Four webcasts covering the entire FDA Blueprint for Prescriber Education for ER/LA Opioid Analgesics (4.00 AMA PRA Category 1 Credits™ available)
  2. A 12-month Quality Improvement (QI) activity for pain and primary care practices in the Philadelphia, PA metropolitan area (20 AMA PRA Category 1 Credits™ available).

Webcasts—Practical Strategies for Safe and Compliant Opioid Prescribing

office visit

Earn up to 4.00 CME Credits

Join nationally recognized pain management experts Charles Argoff, MD, Bill McCarberg, MD, Srinivas Nalamachu, MD, and Joseph Pergolizzi, MD, as they guide you through the ER/LA opioid REMS and its implications for you and your patients. These webcasts will provide you with an in-depth look at how actual pain practices are safely managing chronic pain patients with ER/LA opioid analgesics in an increasingly challenging regulatory environment.

Attention Prescribers: FDA seeks your help in curtailing the U.S. opioid epidemic.

“FDA remains committed to making sure that patients in need have continued access to appropriate pain medications, while also ensuring that all opioid products are used as safely and effectively as possible under the supervision of prescribers armed with sound information and training. Prescribers are critical to successfully curtailing this national problem.”

FDA Open Letter to Prescribers March 1, 2013

Quality Improvement—Build a REMS-Ready Practice


Earn up to 20 CME Credits

Clinical practices in the Philadelphia, PA metropolitan area will assess their current opioid prescribing processes against the FDA Blueprint for Prescriber Education for ER/LA Opioid Analgesics, identify process gaps, and test change concepts with the goal of increased compliance to the FDA REMS standards.

“I strongly encourage your practice to take part in this innovative QI program. At the completion of this activity you will be able to prove—with your own data—that your practice is REMS-compliant.”

Bill H. McCarberg, MD, FABM
Course Director
Founder, Chronic Pain Program
Kaiser Permanente

“All healthcare professionals have 2 jobs.
Job 1 is to provide care.
Job 2 is to improve care.”

The Dartmouth Institute for Health Policy and Clinical Practice
Dartmouth Medical School

Temple University logo

Produced in collaboration with Intelligent Medical Decisions, Inc.

Intelligent Medical Decisions logo

This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).